Literature DB >> 27903116

Endoscopic endonasal versus open transcranial resection of craniopharyngiomas: a case-matched single-institution analysis.

Nelson Moussazadeh1, Vishaal Prabhu1, Evan D Bander1, Ryan C Cusic1, Apostolos John Tsiouris2, Vijay K Anand3, Theodore H Schwartz1,3,4.   

Abstract

OBJECTIVE The authors compared clinical and radiological outcomes after resection of midline craniopharyngiomas via an endoscopic endonasal approach (EEA) versus an open transcranial approach (TCA) at a single institution in a series in which the tumors were selected to be equally amenable to gross-total resection (GTR) with either approach. METHODS A single-institution retrospective review of previously untreated adult midline craniopharyngiomas was performed. Lesions were evaluated by 4 neurosurgeons blinded to the actual approach used to identify cases that were equally amenable to GTR using either an EEA or TCA. Radiological and clinical outcome data were assessed. RESULTS Twenty-six cases amenable to either approach were identified, 21 EEA and 5 TCA. Cases involving tumors that were resected via a TCA had a trend toward larger diameter (p = 0.10) but were otherwise equivalent in preoperative clinical and radiological characteristics. GTR was achieved in a greater proportion of cases removed with an EEA than a TCA (90% vs 40%, respectively; p = 0.009). Endoscopic resection was associated with superior visual restoration (63% vs 0%; p < 0.05), a decreased incidence of recurrence (p < 0.001), lower increase in FLAIR signal postoperatively (-0.16 ± 4.6 cm3 vs 14.4 ± 14.0 cm3; p < 0.001), and fewer complications (20% vs 80% of patients; p < 0.001). Significantly more TCA patients suffered postoperative cognitive loss (80% vs 0; p < 0.0001). CONCLUSIONS An EEA is a safe and effective approach to suprasellar craniopharyngiomas amenable to GTR. For this select group of cases, the EEA may provide higher rates of GTR and visual improvement with fewer complications compared with a TCA.

Entities:  

Keywords:  EEA = endoscopic endonasal approach; EOR = extent of resection; GTR = gross-total resection; TCA = transcranial approach; craniopharyngioma; endonasal; endoscope; oncology; skull base; suprasellar

Mesh:

Year:  2016        PMID: 27903116     DOI: 10.3171/2016.9.FOCUS16299

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  12 in total

1.  Characteristics and overall survival in pediatric versus adult craniopharyngioma: a population-based study.

Authors:  Brandon M Lehrich; Khodayar Goshtasbi; Frank P K Hsu; Edward C Kuan
Journal:  Childs Nerv Syst       Date:  2021-02-28       Impact factor: 1.475

Review 2.  Update on management of craniopharyngiomas.

Authors:  Fraser Henderson; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2021-11-22       Impact factor: 4.130

3.  Surgical Outcomes of Endoscopic Endonasal Surgery in 29 Patients with Craniopharyngioma.

Authors:  Arad Iranmehr; Mostafa Esmaeilnia; Khashayar Afshari; Seyed Mousa Sadrehosseini; Azin Tabari; Morteza Faghih Jouibari; Mehdi Zeinalizadeh
Journal:  J Neurol Surg B Skull Base       Date:  2020-06-19

Review 4.  Essential Management of Pediatric Brain Tumors.

Authors:  Katharina Lutz; Stephanie T Jünger; Martina Messing-Jünger
Journal:  Children (Basel)       Date:  2022-04-02

5.  BRAF V600E mutant papillary craniopharyngiomas: a single-institutional case series.

Authors:  Emanuele La Corte; Iyan Younus; Francesca Pivari; Adelina Selimi; Malte Ottenhausen; Jonathan A Forbes; David J Pisapia; Georgiana A Dobri; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

6.  Clinical study of endoscopic treatment of a sellar pituitary adenomas with sellar diaphragm defect.

Authors:  Zhuoru Jin; Xinyu Wu; Yibao Wang
Journal:  BMC Neurol       Date:  2020-04-11       Impact factor: 2.474

7.  Clinical Outcomes of Transcranial and Endoscopic Endonasal Surgery for Craniopharyngiomas: A Single-Institution Experience.

Authors:  Chuansheng Nie; Youfan Ye; Jingnan Wu; Hongyang Zhao; Xiaobing Jiang; Haijun Wang
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

8.  Craniopharyngioma and the Third Ventricle: This Inescapable Topographical Relationship.

Authors:  José María Pascual; Ruth Prieto
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

9.  Endoscopic Endonasal Transsphenoidal Surgery for Recurrent Craniopharyngiomas.

Authors:  Zhenguang Feng; Chuzhong Li; Lei Cao; Ning Qiao; Wentao Wu; Jiwei Bai; Peng Zhao; Songbai Gui
Journal:  Front Neurol       Date:  2022-04-11       Impact factor: 4.003

10.  Quality of life and olfactory function after suprasellar craniopharyngioma surgery-a single-center experience comparing transcranial and endoscopic endonasal approaches.

Authors:  Sascha Marx; Ioanna Tsavdaridou; Sebastian Paul; Antje Steveling; Cornelia Schirmer; Marton Eördögh; Stephan Nowak; Marc Matthes; Ehab El Refaee; Steffen K Fleck; Joerg Baldauf; Markus M Lerch; Andreas Stahl; Werner Hosemann; Henry W S Schroeder
Journal:  Neurosurg Rev       Date:  2020-07-10       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.